Not registered yet? Please contact our project manager Dr. Mary Gazea . This area is only for members of the research consortium.

DECISION in a nutshell

Full project title:Decompensated cirrhosis: identification of new combinatorial therapies based on systems approaches
Start date:01 April 2020
Duration:66 months (5.5 years)
Members:21 institutions from 10 European countries
EC funding:6 million €
Scientific Coordinator:Prof. Pierre-Emmanuel Rautou (EFCLIF)
Project Manager:Dr. Mary Gazea (concentris)
Number of Work Packages:9
Project fact sheet by the EU:Project fact sheet
facts_and_figures_inline_image

DECISION aims to achieve 4 different goals: (1) To gain a deeper systems level understanding of the pathophysiology leading to cirrhosis, decompensated cirrhosis, and ACLF while respecting individual differences in gender, genetics, and disease history, (2) to provide a proof of concept that novel combinatorial therapies based on systems biology approaches can decrease mortality and significantly improve the lives of patients suffering from cirrhosis, (3) to characterize pathological and therapeutic mechanisms in translational animal models (preclinical research), and (4) to develop robust prognostic and response tests in order to reliably identify patients that are at risk for progression of decompensated cirrhosis following standard treatment but will likely respond well to a novel combinatorial therapy.